ketorolac tromethamine has been researched along with nepafenac in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (90.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, A; Bingaman, DP; Campochiaro, PA; Melia, MB; Mori, K; Nambu, H; Oshima, Y; Saishin, Y; Takahashi, K; Yamamoto, S | 1 |
| McDonald, M; Trattler, W | 1 |
| Amico, LM; Bucci, FA; Waterbury, LD | 1 |
| Chalkley, TH; Duong, HV; Westfield, KC | 1 |
| Walters, T | 1 |
| McCulley, JP | 1 |
| Toyos, R | 1 |
| Holland, E; Lane, S; Lindstrom, R; Raizman, M; Reilly, C | 1 |
| Erdahl, WE; Gadd, ME; Graff, G; Kumar, J; Lal, N; Pfeiffer, DR; Yanni, JM | 1 |
| Arieta, CE; Chaves, FR; da Costa Pinto, AP; Fulco, EA; Lira, RP; Zanetti, FR | 1 |
4 trial(s) available for ketorolac tromethamine and nepafenac
| Article | Year |
|---|---|
Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cornea; Corneal Opacity; Double-Blind Method; Female; Humans; Hyperopia; Keratomileusis, Laser In Situ; Ketorolac Tromethamine; Male; Myopia; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phenylacetates; Prospective Studies; Visual Acuity; Wound Healing | 2007 |
Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzeneacetamides; Biological Availability; Chromatography, High Pressure Liquid; Dinoprostone; Double-Blind Method; Humans; Immunoenzyme Techniques; Ketorolac Tromethamine; Mass Spectrometry; Phacoemulsification; Phenylacetates | 2007 |
Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Double-Blind Method; Female; Humans; Ketorolac Tromethamine; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Pain, Postoperative; Patient Compliance; Patient Satisfaction; Phacoemulsification; Phenylacetates; Prospective Studies; Uveitis, Anterior; Visual Acuity | 2007 |
Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: a randomized trial.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Benzeneacetamides; Cataract Extraction; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Intraoperative Period; Ketorolac Tromethamine; Male; Mydriasis; Ophthalmic Solutions; Phenylacetates; Postoperative Complications; Prednisolone; Preoperative Care; Prodrugs; Retrospective Studies; Single-Blind Method; Treatment Outcome | 2012 |
6 other study(ies) available for ketorolac tromethamine and nepafenac
| Article | Year |
|---|---|
Topical nepafenac inhibits ocular neovascularization.
Topics: Administration, Topical; Animals; Benzeneacetamides; Choroidal Neovascularization; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Endothelial Growth Factors; Intercellular Signaling Peptides and Proteins; Isoenzymes; Ketorolac Tromethamine; Lymphokines; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Ophthalmic Solutions; Phenylacetates; Prodrugs; Prostaglandin-Endoperoxide Synthases; Retinal Neovascularization; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Re: Prostaglandin E(2) inhibition and aqueous concentration of ketorolac 0.4% and nepafenac 0.1% in patients undergoing phacoemulsification.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzeneacetamides; Chromatography, High Pressure Liquid; Dinoprostone; Humans; Immunoenzyme Techniques; Ketorolac Tromethamine; Phacoemulsification; Phenylacetates | 2007 |
Ketorolac versus nepafenac in cataract surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Humans; Ketorolac Tromethamine; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Ophthalmic Solutions; Pain, Postoperative; Patient Compliance; Patient Satisfaction; Phacoemulsification; Phenylacetates; Uveitis, Anterior; Visual Acuity | 2008 |
Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cornea; Corneal Opacity; Double-Blind Method; Humans; Hyperopia; Keratomileusis, Laser In Situ; Ketorolac Tromethamine; Multicenter Studies as Topic; Myopia; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phenylacetates; Randomized Controlled Trials as Topic; Visual Acuity; Wound Healing | 2008 |
Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cornea; Corneal Opacity; Double-Blind Method; Humans; Hyperopia; Keratomileusis, Laser In Situ; Ketorolac Tromethamine; Myopia; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phenylacetates; Randomized Controlled Trials as Topic; Visual Acuity; Wound Healing | 2008 |
Differential effects of non-steroidal anti-inflammatory drugs on mitochondrial dysfunction during oxidative stress.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Celecoxib; Diclofenac; Ketorolac Tromethamine; Male; Membrane Potentials; Mitochondria, Liver; Molecular Structure; Oxidative Stress; Permeability; Phenylacetates; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Temperature; Time Factors | 2009 |